METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS Russian patent published in 2010 - IPC A61K38/21 A61K31/7036 A61P31/06 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to phthisiology, and can be used in treating the patients with pulmonary tuberculosis. That is ensured by conventional tuberculous therapy. The therapeutic course includes Viferon, rectal suppositories containing 1000000 ME of human recombinant alpha-2 interferon. Viferon is dosed one suppository twice day, every 12 hours, the 1^st to 10^th day - daily and the 11^th to 60^th day - every second day.

EFFECT: therapeutic addition of Viferon in treating tuberculosis in specially developed dose and schedule allows improving clinical effectiveness ensured by reduced abacillation time and closure of decomposition cavities, resolution of infiltrative pulmonary changes.

2 tbl, 2 ex